Results 101 to 110 of about 549,379 (280)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma

Chinese Journal of Cancer, 2016
The value of adding induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) for the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear.
Wen-Fei Li, Lei Chen, Ying Sun, Jun Ma
doaj   +1 more source

Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report

BMC Cancer, 2020
Background To the best of our knowledge, no study has reported mediastinal shift accompanied with obstructive atelectasis due to bulky primary esophageal tumor components treated with adaptive radiotherapy and concurrent chemotherapy.
Katsuyuki Sakanaka, Kota Fujii, Takashi Mizowaki   +2 more
doaj   +1 more source

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

Journal of Clinical Oncology, 2018
Purpose To report the results of the Trans Tasman Radiation Oncology Group randomized phase III trial designed to determine whether the addition of concurrent chemotherapy to postoperative radiotherapy (CRT) improved locoregional control in patients with
S. Porceddu, M. Bressel, M. Poulsen, Adam Stoneley, M. Veness, L. Kenny, C. Wratten, J. Corry, S. Cooper, G. Fogarty, M. Collins, Michael Collins, A. Macann, C. Milross, M. Penniment, H. Liu, M. King, B. Panizza, D. Rischin   +18 more
semanticscholar   +1 more source

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20‐17/KM23 trial

Cancer Communications, EarlyView.
Kyoungmin Lee, Kyung‐Hun Lee, Dong‐Wan Kim, Jeesun Yoon, Yoon Ji Choi, Soohyeon Lee, Ju Won Kim, Kyong Hwa Park, Wonyoung Choi, Youngjoo Lee, Hyewon Ryu, Dong‐Hoe Koo, YunGyoo Lee, Hei‐Cheul Jeung, Min‐Young Lee, Namsu Lee, Myoung Joo Kang, Jieun Lee, Sook Hee Hong, Eun Joo Kang, In Hae Park   +20 more
wiley   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

Lobaplatin-based concurrent chemoradiotherapy in elderly nasopharyngeal carcinoma

Annals of Medicine
The therapeutic benefit of concurrent chemoradiotherapy (CCRT) in elderly nasopharyngeal carcinoma (NPC) patients remains controversial. This study aimed to investigate the efficacy and toxicity of lobaplatin-based CCRT in elderly patients with NPC.We included stage II-IVA NPC patients aged ≥65 years who received lobaplatin concomitant with intensity ...
Yi-Feng Yu, Ping Zhou, Rui Zhou, Qin Lin, San-Gang Wu   +4 more
openaire   +3 more sources

The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Systemic platinum‐based chemotherapy is the first‐line treatment of choice for metastatic cervical cancer. While subsequent radiotherapy after primary chemotherapy is a potential option, its benefit remains unclear. This multicenter retrospective study aimed to evaluate whether post‐chemotherapy radiotherapy improves the prognosis of
Ai Miyoshi, Fumiaki Isohashi, Makoto Fujii, Tadashi Iwamiya, Masahiko Takemura, Yoshikazu Nagase, Takeshi Yokoi, Emi Yoshioka, Kimihiko Ito, Eri Yamabe, Kanji Masuhara, Tomoko Tsujie, Tadashi Kimura, Michiko Kodama   +13 more
wiley   +1 more source

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma

Cancer Communications, 2019
The standard of care for patients with locoregionally advanced nasopharyngeal carcinoma is concurrent platinum-based chemoradiotherapy. Existing literature have demonstrated that the addition of gemcitabine and cisplatin as induction chemotherapy in ...
Yuan Zhang, Ying Sun, Jun Ma
doaj   +1 more source

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy

International Journal of Molecular Sciences, 2019
Neoadjuvant concurrent chemoradiotherapy (CCRT), followed by radical proctectomy, is the standard treatment for locally advanced rectal cancer. However, a poor response and therapeutic resistance continue to occur despite this treatment.
Hui-Ching Wang, Chia-Lin Chou, Ching-Chieh Yang, Wei-lun Huang, Yin-Chou Hsu, C. Luo, Tzu-Ju Chen, Chien-Feng Li, Mei-Ren Pan   +8 more
semanticscholar   +1 more source

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Recent studies addressing the role of adjuvant chemotherapy (AC) in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability.
Yoon Soo Chae, Youngmin Han, Go‐Won Choi, Younsoo Seo, Inhyuck Lee, Won‐Gun Yun, Hye‐Sol Jung, Wooil Kwon, Joon Seong Park, Jin‐Young Jang   +9 more
wiley   +1 more source